<DOC>
	<DOCNO>NCT02974777</DOCNO>
	<brief_summary>The purpose study determine efficacy safety routine individualize antiplatelet therapy coronary stent implantation evaluate `` on-treatment '' platelet reactivity Multiple Electrode Aggregometry ( MEA , MultiplateÂ® Analyzer ) . IDEAL-PCI Extended continuation IDEAL-PCI registry additional focus bleed event net clinical benefit</brief_summary>
	<brief_title>The IDEAL-PCI Extended Registry</brief_title>
	<detailed_description>Determination platelet reactivity patient percutaneous coronary Intervention describe IDEAL-PCI registry . In IDEAL-PCI Extended Registry additional deescalation arm reduction standard dual antiplatelet therapy ( DAPT ) dosis case low platelet reactivity P2Y12 Inhibition Aspirin without bleed implement .</detailed_description>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>consecutive PCI patient pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>